Page 11 - The Indian EYE 070921
P. 11
NATION JULY 09, 2021 | The Indian Eye 11
ing against COVID-19, starting COVID-19 vaccine so that the tinuously in touch with Pfizer, company is in the final stages to
14 days after the first dose. Dr application is processed well in but no decision has been taken get approval for the COVID-19
VK Paul, NITI Aayog member time but Pfizer has not applied particularly over granting pro- vaccine in India.
health and Chair of the Nation- for the license yet, said sources tection against legal liability. The new phase of univer-
al Expert Group on Vaccine on Tuesday. According to the Notably, in June, Pfizer CEO salization of COVID-19 vacci-
Administration (NEGVAC) for sources, the government is con- Albert Bourla had said that the nation commenced from June
COVID-19, said that the Mod- 21, 2021. The vaccination drive
erna vaccine will be adminis- has been ramped up through
tered in two doses. availability of more vaccines,
“New drug permission has advance visibility of vaccine
been granted to Moderna, the availability to states and UTs
first internationally developed for enabling better planning by
vaccine. This new drug permis- them, and streamlining the vac-
sion is for restricted use. There cine supply chain.
are four vaccines now Covaxin, As part of the nationwide
Covishield, SputnikV and Mod- vaccination drive, Government
erna. We will soon close the deal of India has been supporting
on Pfizer as well,” Dr Paul said. the states and UTs by providing
“These four vaccines (Co- them COVID vaccines free of
vaxin, Covishield, SputnikV and cost. In the new phase of the uni-
Moderna) are safe for lactating versalisation of the COVID-19
mothers. The vaccine has no asso- vaccination drive, the Union
ciation with infertility,” he added. Government will procure and
Also, the Indian drug reg- supply (free of cost) 75 per cent
ulator has urged Pfizer twice People wait to receive a dose of the COVID-19 vaccine outside a vaccina- of the vaccines being produced
in writing to apply for emer- tion centre in Gurugram on Tuesday. (ANI) by the vaccine manufacturers in
gency use authorization for its the country to states and UTs.
www.TheIndianEYE .com